Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial
From MaRDI portal
Publication:3303671
Recommendations
- Distribution-based causal inference models for the estimation of therapy effects in randomized and controled clinic studies.
- Nonparametric inference for assessing treatment efficacy in randomized clinical trials with a time-to-event outcome and all-or-none compliance
- Modeling survival distribution as a function of time to treatment discontinuation: a dynamic treatment regime approach
- Uses and limitations of randomization-based efficacy estimators
- Uses and limitations of randomization-based efficacy estimators
Cites work
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
- Causal effect models for realistic individualized treatment and intention to treat rules
- Estimation of Regression Coefficients When Some Regressors Are Not Always Observed
- Inference and missing data
Cited in
(3)- Direct estimation of the mean outcome on treatment when treatment assignment and discontinuation compete
- Modeling survival distribution as a function of time to treatment discontinuation: a dynamic treatment regime approach
- Estimating mean potential outcome under adaptive treatment length strategies in continuous time
This page was built for publication: Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3303671)
